• Profile
Close

Risk factors and outcomes of revisions on arteriovenous hemodialysis access

Journal of Vascular Surgery Sep 23, 2019

Rockley M, et al. - Researchers conducted a retrospective cohort study of all patients undergoing chronic hemodialysis (HD) for more than 3 months in the Champlain NephroCare network to determine the risk factors and durability of revision on arteriovenous access (AV) access sites for patients on chronic HD. Description of 2,018 eligible AV access creations in 787 patients was identified. These were composed of 1,808 arteriovenous access using a fistula (90%) and 210 arteriovenous access using a graft (10%). Among AV, at least one revision was required in 67% and there were 12% that received two or more revisions. These revisions sustained limited durability after the procedure. Revisions were most commonly angioplasty (95.8%). Repeated revisions, especially on lower arm, AVG, or occluded access sites, seem to be particularly futile.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay